MonOrail to Cure? Targeting Orai1 to Reverse Pulmonary Arterial Hypertension.

Abstract

HomeCirculation ResearchVol. 131, No. 9MonOrail to Cure? Targeting Orai1 to Reverse Pulmonary Arterial Hypertension No AccessEditorialRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessEditorialRequest AccessFull TextMonOrail to Cure? Targeting Orai1 to Reverse Pulmonary Arterial Hypertension Tatiana V. Kudryashova and Elena A. Goncharova Tatiana V. KudryashovaTatiana V. Kudryashova https://orcid.org/0000-0002-2843-5554 Lung Center, Division of Pulmonary, Critical Care and Sleep Medicine, University of California, Davis School of Medicine. Search for more papers by this author and Elena A. GoncharovaElena A. Goncharova Correspondence to: Elena Goncharova, PhD, GBSF Rm 6523, 451 Health Sciences Dr, Davis, CA 95616. Email E-mail Address: [email protected] https://orcid.org/0000-0001-7118-6752 Lung Center, Division of Pulmonary, Critical Care and Sleep Medicine, University of California, Davis School of Medicine. Search for more papers by this author Originally published13 Oct 2022https://doi.org/10.1161/CIRCRESAHA.122.321924Circulation Research. 2022;131:728–730This article is a commentary on the followingOrai1 Inhibitors as Potential Treatments for Pulmonary Arterial HypertensionFootnotesThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.Correspondence to: Elena Goncharova, PhD, GBSF Rm 6523, 451 Health Sciences Dr, Davis, CA 95616. Email [email protected]edu